Literature DB >> 18047540

ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands.

Rinse K Weersma1, Alexandra Zhernakova, Ilja M Nolte, Céline Lefebvre, John D Rioux, Flip Mulder, Hendrik M van Dullemen, Jan H Kleibeuker, Cisca Wijmenga, Gerard Dijkstra.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD)--Crohn's disease (CD) and ulcerative colitis (UC)--and celiac disease are intestinal inflammatory disorders with a complex genetic background. Recently, two novel genes were found to be associated with IBD susceptibility. One, an uncommon coding variant (rs11209026) in the gene encoding for the interleukin-23 receptor (IL23R), conferred strong protection against CD. The other, rs2241880 in the autophagy-related 16-like 1 gene (ATG16L1), was associated with CD. We performed a case-control study for the association of IBD with IL23R and ATG16L1 in a Dutch cohort. We also looked at the association of IL23R and ATG16L1 with celiac disease.
METHODS: Five hundred eighteen Dutch white IBD patients (311 CD and 207 UC, including 176 trios of patients with both parents), 508 celiac disease patients, and 893 healthy controls were studied for association with the rs11209026 (IL23R) and rs2241880 (ATG16L1) single nucleotide polymorphisms (SNP).
RESULTS: The rs11209026 SNP in IL23R had a protective effect for IBD in the case-control analysis (odds ratio [OR] 0.19, 95% confidence interval [CI] 0.10-0.37, P= 6.6E-09). Both CD (OR 0.14, CI 0.06-0.37, P= 3.9E-07) and UC (OR 0.33, CI 0.15-0.73, P= 1.4E-03) were associated with IL23R. For ATG16L1, the rs2241880 SNP was associated with CD susceptibility (OR 1.36, CI 1.12-1.66, P= 0.0017). The population-attributable risk of carrying allele G is 0.24 and is 0.19 for homozygosity for allele G in CD. No association was found between IL23R or ATG16L1 and celiac disease.
CONCLUSIONS: We confirmed the association of IL23R and ATG16L1 with CD susceptibility and also the association of IL23R with UC. We found IL23R and ATG16L1 were not associated with celiac disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18047540     DOI: 10.1111/j.1572-0241.2007.01660.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  34 in total

Review 1.  Detecting shared pathogenesis from the shared genetics of immune-related diseases.

Authors:  Alexandra Zhernakova; Cleo C van Diemen; Cisca Wijmenga
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

2.  Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.

Authors:  Toshihiko Okazaki; Ming-Hsi Wang; Patricia Rawsthorne; Michael Sargent; Lisa Wu Datta; Yin Yao Shugart; Charles N Bernstein; Steven R Brant
Journal:  Inflamm Bowel Dis       Date:  2008-11       Impact factor: 5.325

3.  NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.

Authors:  Jurgita Sventoraityte; Aida Zvirbliene; Andre Franke; Ruta Kwiatkowski; Gediminas Kiudelis; Limas Kupcinskas; Stefan Schreiber
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

4.  IL23R haplotypes provide a large population attributable risk for Crohn's disease.

Authors:  Kent D Taylor; Stephan R Targan; Ling Mei; Andrew F Ippoliti; Dermot McGovern; Emebet Mengesha; Lily King; Jerome I Rotter
Journal:  Inflamm Bowel Dis       Date:  2008-09       Impact factor: 5.325

Review 5.  ATG16L1: A multifunctional susceptibility factor in Crohn disease.

Authors:  Mohammad Salem; Mette Ammitzboell; Kris Nys; Jakob Benedict Seidelin; Ole Haagen Nielsen
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

Review 6.  Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease.

Authors:  Lynn Cotterill; Debbie Payne; Scott Levinson; John McLaughlin; Emma Wesley; Mark Feeney; Hilary Durbin; Simon Lal; Alistair Makin; Simon Campbell; Stephen A Roberts; Catherine O'Neill; Cathryn Edwards; William G Newman
Journal:  Can J Gastroenterol       Date:  2010-05       Impact factor: 3.522

Review 7.  The use of prognostic factors in inflammatory bowel diseases.

Authors:  Thomas Billiet; Marc Ferrante; Gert Van Assche
Journal:  Curr Gastroenterol Rep       Date:  2014-11

Review 8.  Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility.

Authors:  Byong Duk Ye; Dermot P B McGovern
Journal:  Expert Rev Clin Immunol       Date:  2016-06-15       Impact factor: 4.473

9.  Genetic association of nonsynonymous variants of the IL23R with familial and sporadic inflammatory bowel disease in women.

Authors:  Zhenwu Lin; Lisa Poritz; Andre Franke; Tong-Yi Li; Andreas Ruether; Kathryn A Byrnes; Yunhua Wang; Anthony W Gebhard; Colin MacNeill; Neal J Thomas; Stefan Schreiber; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

10.  Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy.

Authors:  Anna Latiano; Orazio Palmieri; Maria Rosa Valvano; Renata D'Incà; Salvatore Cucchiara; Gabriele Riegler; Anna Maria Staiano; Sandro Ardizzone; Salvatore Accomando; Gian Luigi de Angelis; Giuseppe Corritore; Fabrizio Bossa; Vito Annese
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.